Advances in systems biology: Measurement, modeling and representation

Current Opinion in Drug Discovery and Development

Volumn 9, Issue 2, 2006, Pages 240-250

  Stephens, Susie M ^a   Rung, Johan ^b  

^a Oracle   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Data integration; Instrumentation; Network analysis; Omics; Semantic web; Systems biology

Indexed keywords

DATA ANALYSIS; DATA COLLECTION METHOD; DRUG INDUSTRY; GENETIC VARIABILITY; GENOMICS; HIGH THROUGHPUT SCREENING; MEASUREMENT; METABOLOMICS; MODEL; PROTEOMICS; REVIEW; SCIENCE; TECHNOLOGY;

ANIMALS; BIOLOGY; DATA INTERPRETATION, STATISTICAL; GENOMICS; HUMANS; MODELS, GENETIC; MODELS, STATISTICAL; PROTEOMICS; SYSTEMS THEORY;

EID: 33645029027     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (138)

1. Pennisi E: Human genome. A low number wins the GeneSweep pool. Science (2003) 300(5625):1484
2. Ensembl: Wellcome Trust Sanger Institute/European Bioinformatics Institute, Hinxton, UK. http://www.ensembl.org Provides a list of 24,192 gene predictions, including 1976 pesudogenes (release 35, 28 November 2005).
3. Thanaraj TA, Stamm S, Clark F, Riethoven JJ, Le Texier V, Muilu J: ASD: The alternative splicing database. Nucleic Acids Res (2004) 32:D64-D69
4. O'Donovan C, Apweiler R, Bairoch A: The human proteomics initiative (HPI). Trends Biotechnol (2001) 19(5):178-181.
5. Hood L, Galas D: The digital code of DNA. Nature (2003) 421(6921):444-448.
6. dbSNP: Single nucleotide polymorphism database: National Center for Biotechnology Information, Bethesda, MD, USA. http://ww. ncbi.nlm.nih.gov/SNP/ index.html Provides a list of 10,430,753 refSNP clusters (build 125, 28 November 2005).
7. Myers S, Bottolo L, Freeman C, McVean G, Donnelly P: A fine-scale map of recombination rates and hotsports across the human genome. Science (2005) 310(5746):321-324.
8. The International HapMap Consortium: A haplotype map of the human genome. Nature (2005) 437(7063):1299-1320. Provides a catalog of genetic variation in the human genome, which will have enormous impact on the discovery of disease-related genes.
9. Matsuzaki H, Dong S, Loi H, Di X, Liu G, Hubbell E, Law J, Berntsen T, Chadha M, Hui H, Yang G et al: Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods (2004) 1(2):109-111.
10. Gunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS: A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet (2005) 37(5):549-554.
11. Hardenbol P, Yu F, Belmont J, MacKenzie J, Bruckner C, Brundage T, Boudreau A, Chow S, Eberle J, Erbilgin A, Falkowski M, et al. Highly multiplexed molecular inversion probe genotyping: Over 10,000 SNPs genotyped in a single tube assay. Genome Res (2005) 15(2):269-275.
12. Hardenbol P, Banér J, Jain M, Nilsson M, Namsaraev EA, Karlin-Neumann GA, Fakhrai-Rad H, Ronaghi M, Willis TD, Landegren U, Davis RW: Multiplexed genotyping with sequence-tagged molecular inversion probes. Nat Biotechnol (2003) 21(6):673-678.
13. Patil N, Berno AJ, Hinds DA, Barrett WA, Doshi JM, Hacker CR, Kautzer CR, Lee DH, Marjoribanks C, McDonough DP, Nguyen BTN, et al: Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science (2001) 294(5547):1719-1723.
14. Silverman AP, Kool ET: Quenched probes for highly specific detection of cellular RNAs. Trends Biotechnol (2005) 23(5):225-230.
15. Elowitz MB, Levins AJ, Siggia ED, Swain PS: Stochastic gene expression in a single cell. Science (2002) 297(5584):1183-1186.
16. Rual J-F, Ceron J, Koreth J, Hao T, Nicot A-S, Hirozane-Kishikawa T, Vandenhaute J, Orkin SH, Hill DE, van den Heuvel S, Vidal M: Towards improving Caenorhabditis elegant phenome mapping with an ORFeome-based RNAi library. Genome Res (2004) 14(10B):2162-2168.
17. Lum L, Yao S, Mozer B, Rovescalli A, Von Kessler D, Nirenberg M, Beachy PA: Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science (2003) 299(5615):2039-2045.
18. Boutros M, Kiger AA, Armknecht S, Kerr K, Hild M, Koch B, Haas SA, Consortium HF, Paro R, Perrimon N: Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science (2004) 303(5659):832-835.
19. Zheng L, Liu J, Batalov S, Zhou D, Orth A Ding S, Schultz PG: An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc Natl Acad Sci USA (2004) 101(1):135-140. Describes an interesting application of RNAi technology to mammalian cells, thereby helping to improve our knowledge of gene function and response to disease, by using a more similar model to humans.
20. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, Ahringer J, Ruvkun G: Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature (2003) 421(6920):268-272.
21. Pothof J, van Haaften G, Thijssen KL, Kamath RS, Fraser AG, Ahringer J, Plasterk RH, Tijsterman M: Identification of genes that protect the C elegans genome against mutations by genome-wide RNAi. Genes Dev (2003) 17(4):443-448.
22. Lee SS, Lee RY, Fraser AG, Kamath RS, Ahringer J, Ruvkun G: A systematic RNAi screen identifies a critical role for mitochondria in C elegans longevity. Nat Genet (2003) 33(1):40-48.
23. Paddison PJ, Silva JM, Conklin DS, Schlabach M, Li M, Aruleba S, Balija V, O'Shaughnessy A, Gnoj L, Scobie K, Chang K et al: A resource for large-scale RNA-interference-based screens in mammals. Nature (2004) 428(6981):427-431.
24. Berns K, Hijams EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madirejo M, Nijkamp W, Weigelt B, Agami R et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature (2004) 428(6981):431-437. Describes an interesting application of RNAi technology to gain further understanding of disease.
25. Shinagawa T, Ishii S: Generation of ski-knockdown mice by expressing a long double-strand RNA from an RNA polymerase II promoter. Genes Dev (2003) 17(11):1340-1345.
26. Hemann MT, Fridman JS, Zilfou JT, Hemando E, Paddison PJ, Cordon-Cardo C, Hannon GJ, Lowe SW: An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet (2003) 33(3):396-400.
27. Nedelkov D, Nelson RW: Surface plasmon resonance mass spectrometry: Recent progress and outlooks. Trends Biotechnol (2003) 21(7):301-305.
28. Schneider LV, Hall MP: Stable isotope methods for high-precision proteomics. Drug Disc Today (2005) 10(5):353-363.
29. Schneider LV, Hall MP, Brasseur MM: Mass-defect tagging for proteomic analysis. Genet Eng News (2004) 24(8):28-30
30. Hall MP, Schneider LV: Isotope differentiated binding energy shifts tags (IDBEST) for improved targeted biomarker discovery and validation. Expert Rev Proteomics (2004) 1(4):421-431.
31. Righetti PG, Campostrini N, Pascali J, Hamdan M, Astner H: Quantitative proteomics: A review of different methodologies. Eur J Mass Spectrom (2004) 10(3):335-348.
32. Nielsen UB, Cardone MH, Sinskey AJ, MacBeath G, Sorger PK: Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc Natl Acad Sci (2003) 100(16):9330-9335.
33. Espina V, Woodhouse EC, Wulfkuhle J, Asmussen HD, Petricoin EF 3rd, Liotta LA: Protein microarray detection strategies: Focus on direct detection technologies. J Immunol Methods (2004) 290(12):121-133.
34. Ivanov SS, Chung AS, Yuan ZL, Guan YJ, Sachs KV, Reicher JS, Chin YE: Antibodies immobilized as arrays to profile protein posttranslational modifications in mammalian cells. Mol Cell Proteomics (2004) 3(8):788-795.
35. Gembitsky DS, Lawlor K, Jacovina A, Yaneva M, Tempst P: A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Mol Cell Proteomics (2004) 3(11):1102-1118.
36. Miller JC, Zhou H, Kwekel J, Cavallo R, Burke J, Butler EB, Teh BS, Haab BB: Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers. Proteomics (2003) 3(1):56-63. Describes the application of protein microarray screens to the identification of protein biomarkers in diseased versus healthy sera.
37. Belov L, Huang P, Barber N, Mulligan SP, Christopherson RI: Identification of repertoires of surface antigens on leukemias using an antibody microarray. Proteomics (2003) 3(11):2147-2154. Describes a study comparing protein expression in healthy and leukemic blood.
38. Stoll D, Templin MF, Bachmann J, Joos TO: Protein microarrays: Applications and future challenges. Curr Opin Drug Discovery Dev (2005) 8(2):239-252. Provides an excellent review of protein microarrays.
39. Salwinski L, Eisenberg D: In silico simulation of biological network dynamics. Nat Biotechnol (2004) 22(8):1017-1019.
40. Bowers PM, Pellegrini M, Thompson MJ, Fierro J, Yeates TO, Eisenberg D: Prolinks: A database of protein functional linkages derived from coevolution. Genome Biol (2004) 5(5):R35.
41. Causier B: Studying the interactome with the yeast two-hybrid system and mass spectrometry. Mass Spectrometry Rev (2003) 23:350-367.
42. Tong AH, Drees B, Nardelli G, Bader GD, Brannetti B, Castagnoli L, Evangdista M, Ferracuti S, Nelson B, Paoluzi S, Quondam M et al: A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules. Science (2002) 295(5553):321-324.
43. Parsons AB, Brost RL, Ding H, Li Z, Zhang C, Sheikh B, Brown GW, Kane PM, Hughes TR, Boone C: Integration of chemical-genetics and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol (2003) 22(1):62-69.
44. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N et al: Towards a proteome scale map of the human protein-protein interaction network. Nature (2005) 437(7062):1173-1178.
45. Suthram S, Sittler T, Ideker T: The Plasmodium protein network diverges from those of other eukaryotes. Nature (2005) 438(7064):108-112.
46. Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y: A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA (2001) 98(8):4569-4574.
47. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, Qureshi-Emili A et al: A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature (2000) 403(6770):623-627.
48. Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, Schultz J, Rick JM, Michon AM, Cruciat CM, Remor M et al: Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature (2002) 415(6868):141-147.
49. Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, Adams SL, Millar A, Taylor P, Bennett K, Boutilier K, Yang L et al: Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature (2002) 415(6868):180-183.
50. Bader GD, Betel D, Hogue CW: BIND: The Biomolecular Interaction Network Database. Nucleic Acids Res (2003) 31(1):248-250.
51. Xenarios I, Rice DW, Salwinski L, Baron MK, Marcotte EM, Eisenberg D: DIP: The Database of Interacting Proteins. Nucleic Acids Res (2000) 28(1):289-291.
52. Hermjakob H, Montecchi-Palazzi L, Lewington C, Mudali S, Kerrien S, Orchard S, Vingron M, Roechert B, Roepstorff P, Valencia A, Margalit H et al: IntAct: An open source molecular interaction database. Nucleic Acids Res (2004) 32:D452-D455.
53. Huh W-K, Falvo JV, Gerke LC, Carroll AS, Howson RW, Weissman JS, O'Shea EK: Global analysis of protein localization in budding yeast. Nature (2003) 425(6959):686-691.
54. 1 protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc Natl Acad Sci USA (2003) 100(26):16077-16082.
55. Huang K, Murphy RF: Boosting accuracy of automated classification of fluorescence microscope images for location proteomics. BMC Bioinformatics (2004) 5:78.
56. Murphy RF: Automated interpretation of protein subcellular location patterns: Implications for early cancer detection and assessment Ann NY Acad Sci (2004) 1020:124-131. Describes the use of fluorescence microscopy analysis for determining the subcellular location of proteins. An interesting discussion is provided of the possible use of automated pattern analysis methods for improving detection of abnormal cells.
57. Meyer T, Teruel MN: Fluorescence imaging of signaling networks. Trends Cell Biol (2003) 13(2):101-106.
58. Weckwerth W: Metabolomics in systems biology. Ann Rev Plant Biol (2003) 54:669-689.
59. Castrillo JI, Oliver SG: Yeast as a touchstone in post-genomic research: Strategies for integrative analysis in functional genomics. J Biocem Mol Biol (2004) 37(1):93-106.
60. Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB: Metabolomics by numbers: Acquiring and understanding global metabolite data. Trends Biotechnol (2004) 22(5):245-252.
61. Kell DB: Metabolomics and systems biology: Making sense of the soup. Curr Opin Microbiol (2004) 7(3):296-307.
62. Dunn WB, Ellis DI: Metabolomics: Current analytical platforms and methodologies. Trends Anal Chem (2005) 24(4):285-294.
63. Weckwerth W, Wenzel KM, Fiehn O: Process for the integrated extraction identification, and quantification of metabolites, proteins and RNA to reveal their co-regulation in biochemical networks. Proteomics (2004) 4(1):78-83.
64. Wagner C, Sefkow M, Kopka J: Construction and application of a mass spectral and retention time index database generated from plant GC/EI-TOF-MS metabolite profiles. Phytochemistry (2003) 62(6):887-900.
65. Broeckling CD, Huhman DV, Farag MA, Smith JT, May GD, Mendes P, Dixon RA, Sumner LW. Metabolic profiling of Medicago truncatula cell cultures reveals the effects of biotic and abiotic ellcitors on metabolism. J Exp Botany (2003) 56(410):323-336.
66. Jonsson P, Gullberg J, Nordström A, Kusano M, Kowalczyk M, Sjöström M, Moritz T: A strategy for identifying differences in large series of metabolomic sample analyzed by GC/MS. Anal Chem (2004) 76(6):1738-1745.
67. Nassar AE, Talaat RE: Strategies for dealing with metabolite elucidation in drug discovery and development. Drug Disc Today (2004) 9(7):317-327.
68. Hood L, Heath JR, Phelps ME, Lin B: Systems biology and new technologies enable predictive and preventative medicine. Science (2004) 306(5698):640-643.
69. Jain KK: Nanobiotechnology: Applications, markets and companies: JaiIn PharmaBiotech, Basel, Switzerland (2005). http://www.pharmabiotech.ch/reports/ nanobiotechnology/
70. Geho DH, Lahar N, Ferrari M, Petricoin EF, Liotta LA: Opportunities for nanotechnology-based innovation in tissue proteomics. Biomed Microdevices (2004) 6(3):231-239.
71. Li J, Tremblay TL, Harrison J, Thibault P: Integrated system for rapid proteomics analyses using microfluidic devices coupled to nanoelectrospray mass spectrometry. Methods Mol Biol (2004) 276:305-324.
72. Heath JR, Phelps ME, Hood L: NanoSystems biology. Mol Imaging Biol (2003) 5(5):312-325.
73. Hubner N, Wallace CA, Zimdahl H, Petretto E, Schulz H, Maciver F, Mueller M, Hummel O, Monti J, Zidek V, Musilova A et al: Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet (2005) 37(3):243-253.
74. Chesler EJ, Lu L, Shou S, Qu Y, Gu J, Wang J, Hsu HC, Mountz JD, Baldwin NE, Langston MA, Threadgill DW et al: Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat Genet (2005) 37(3):233-242.
75. Bystrykh L, Weersing E, Dontje B, Sutton S, Pletcher MT, Wiltshire T, Su AI, Vellenga E, Wang J, Manly KF, Lu L et al: Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'. Nat Genet (2005) 37(3):225-232.
76. Schadt EE, Lamb J, Yang X, Zhu J, Edwards S, Guhathakurta D, Sieberts SK, Monks S, Reitman M, Zhang C, Lum PY et al: An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet (2005) 37(7):710-717.
77. Mehrabian M, Allayee H, Stockton J, Lum PY, Drake TA, Castellani LW, Suh M, Armour C, Edwards S, Lamb J, Lusis AJ et al. Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat Genet (2005) 37(11):1224-1233. Describes a combination of the analysis of expression quantitative trait loci with gene perturbation experiments to implicate a specific gene and its involvement in obesity and bone traits.
78. Gibson G, Weir B: The quantitative genetics of transcription. Trends Genet (2005) 21(11):616-623.
79. Stamatoyannopoulos JA: The genomics of gene expression. Genomics (2004) 84(3):449-457.
80. Hirschhorn JN, Daly MJ: Genome-wide association studies for common diseases and complex traits. Nat Rev Genet (2005) 6(2):95-108.
81. Bergmann S, Ihmels J, Barkai N: Similarities and differences in genome-wide expression data of six organisms. PLOS Biol (2004) 2(1):E9 Provides combined gene sequence and expression data for six organisms and analyzes the resulting gene networks to provide further understanding of how the cell is constructed and designed.
82. Tewari M, Hu PJ, Ahn JS, Ayivi-Guedehoussou N, Vidalain PO, Li S, Milstein S, Armstrong CM, Boxem M, Butler MD, Busiguina S et al: Systematic interactome mapping and genetic perturbation analysis of a C elegans TGF-β signaling network. Mol Cell (2004) 13(4):469-482. Describes the application of a Y2H screen to identify interacting proteins. RNAi was used to knock down genes that had been derived from the interactome map. This double approach helped to identify false negatives in both experimental approaches.
83. Walhout AJ, Reboul J, Shtanko O, Bertin N, Vaglio P, Ge H, Lee H, Doucette-Stamm L, Gunsalus KC, Schetter AJ, Morton DG et al: Integrating interactome, phenome and transcriptome mapping data for the C elegans germline. Curr Biol (2002) 12(22):1952-1958.
84. Herrgard MJ, Covert MW, Palsson BO: Reconciling gene expression data with known genome-scale regulatory network structures. Genome Res (2003) 13(11):2423-2434.
85. Nagaraj VH, O'Flanagan RA, Bruning AR, Mathias JR, Vershon AK, Sengupta AM: Combined analysis of expression data and transcription factor binding sites in the yeast genome. BMC Genomics (2004) 5(1):59.
86. Morgenthal K, Wienkoop S, Scholz M, Selbig J, Weckwerth W: Correlative GC-TOF-MS based metabolite profiling and LC-MS based protein profiling reveal time-related systemic regulation of metabolite-protein networks and improve pattern recognition for multiple biomarker selection. Metabolomics (2005) 1(2):109-121.
87. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K, Cruciat C, Eberhard D, Gagneur J, Ghidelli S, Hopf C et al: A physical and functional map of the human TNF-α/NF-κB signal transduction pathway. Nat Cell Biol (2004) 6(2):97-105.
88. Barabási A-L, Albert R: Emergence of scaling in random networks. Science (1999) 286(5439):509-512. The first paper to describe real world, scale-tree networks and to propose a generative model.
89. Jeong H, Tombor B, Albert R, Ottvai ZN, Barabási A-L: The large-scale organization of metabolic networks. Nature (2000) 407(6804):651-654.
90. Yook S-H, Ottavi ZN, Barabási AL: Functional and topological characterization of protein interaction networks. Proteomics (2004) 4(4):928-942. Provides details of a study to uncover the generic large-scale properties of protein-protein interactions in yeast, and to determine the impact of protein function and cellular localization on the network topology.
91. Han J-D, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP, Vidal M: Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature (2004) 430(6995):88-93. Discusses the different spatiotemporal binding dynamics of hubs in the protein interaction network in yeast.
92. Zaslaver A, Mayo AE, Rosenberg R, Bashkin P, Sberro H, Tsalyuk M, Surette MG, Alon U: Just-in-time transcription program in metabolic pathways. Nat Genet (2005) 36(5):486-491. Describes the strength and timing of the expression of genes in a well-characterized amino acid biosynthesis pathway. The response time for activation of each gene was demonstrated to be dependent on its location in the pathway, indicating a 'just-in-time' production principle of the resulting enzymes.
93. Zeitlinger J, Simon I, Harbison CT, Hannett NM, Volkert TL, Fink GR, Young RA: Program-specific distribution of a transcription factor dependent on partner transcription factor and MAPK signaling. Cell (2003) 113(3):395-404.
94. Luscombe NM, Babu MM, Yu H, Snyder M, Teichmann SA, Gerstein M: Genomic analysis of regulatory network dynamics reveals large topological changes. Nature (2004) 431(7006):308-312. Describes the first genome-scale study of how biological networks are rewired according to the needs of the cell. Patterns of gene expression were examined during the cell cycle, sporulation, diauxic shift, DNA damage and the stress response, and sub-networks of interactions that were active under different conditions were identified.
95. Danial NN, Gramm CF, Scorrano L, Zhang CY, Krauss S, Ranger AM, Datta SR, Greenberg ME, Licklider U, Lowell BB, Gygi SP et al: BAD and glucokinase reside in a mitochondrial complex that integrates glycolysls and apoptosis. Nature (2003) 424(6951):952-956.
96. Lappe M, Holm L: Unraveling protein interaction networks with near-optimal efficiency. Nat Biotechnol (2004) 22(1):98-103.
97. Albert R: Scale-free networks in cell biology. J Cell Sci (2005) 118(Pt 21):4947-4957.
98. Pedraza JM, van Oudenaarden A: Noise propagation in gene networks. Science (2005) 307(5717):1965-1989. Describes a dynamic model of how noise in gene expression propagates through a gene network, based on gene expression measurements in single cells.
99. Rosenfeld N, Young JW, Alon U, Swain PS, Elowitz MB: Gene regulation at the single-cell level. Science (2005) 307(5717):1982-1965. Describes how fluctuations in gene expression on different time scales affect the accuracy of downstream protein production.
100. Yokobayashi, Y, Weiss R, Arnold FH: Directed evolution of a genetic circuit Proc Natl Acad Sci USA (2002) 99(26):16587-16591.
101. Fung E, Wong WW, Suen JK, Bulter T, Lee S, Liao JC: A synthetic gene-metabolic oscillator. Nature (2005) 436(7038):118-122.
102. Chan LY, Kosuri S, Endy D: Refactoring bacteriophage T7. Mol Syst Biol (2005) 1(msb4100025):E1-E10.
103. Isaacs FJ, Dwyer DJ, Ding C, Pervouchine DD, Cantor CR, Collins JJ: Engineered riboregulators enable post-transcriptional control of gens expression. Nat Biotechnol (2005) 22(7):841-847. Describes a RNA-based system for artificial positive and negative control of gene expression by interfering with ribosome binding.
104. Kaem M, Blake WJ, Collins JJ: The engineering of gene regulatory networks. Ann Rev Biomed Eng (2003) 5:179-206.
105. Hasty J, McMillen D, Collins JJ: Engineered gene circuits. Nature (2002) 420(6912):224-230.
106. Brenner SA, Sismour AM: Synthetic biology. Nat Rev Genet (2005) 6:533-543.
107. Kaem M, Elston TC, Blake WJ, Collins JJ: Stochasticity in gene expression: From theories to phenotypes. Nat Rev Genet (2005) 6(6):451-484. Provides an excellent review of the influence of noise on gene regulatory systems.
108. Asthana S, King OD, Gibbons FD, Roth FP: Predicting protein complex membership using probabilistic network reliability. Genome Res (2004) 14(6):1170-1175.
109. Wong SL, Zhang LV, Tong AH, Li Z, Goldberg DS, King OD, Lesage G, Vidal M, Andrews B, Bussey H, Boone C et al: Combining biological networks to predict genetic interactions. Proc Natl Acad Sci USA (2004) 101(44):15682-15687.
110. Zhang LV, Wong SL, King OD, Roth FP: Predicting co-complexed protein pairs using genomic and proteomic data integration. BMC Bioinformatics (2004) 5:38.
111. Holzhutter HG: The principle of flux minimization and its application to estimate stationary fluxes in metabolic networks. Eur J Biochem (2004) 271(14):2905-2922.
112. Price ND, Schellenberger J, Palsson BO: Uniform sampling of steady state flux spaces: Means to design experiments and to interpret enzymopathies. BioPhys J (2004) 87(4):2172-2186.
113. Segre D, Zucker J, Katz J, Lin X, D'Haeseleer P, Rindone WP, Kharchenko P, Nguyen DH, Wright MA, Church GM: From annotated genomes to metabolic flux models and kinetic parameter fitting. OMICS (2003) 7(3):301-316.
114. Searls DB: Data integration: Challenges for drug discovery. Nat Rev Drug Discov (2005) 4(1):45-58.
115. Donnelly B: Data integration technologies: An unfulfilled revolution in the drug discovery process? Drug Disc Today Biosilico (2003) 1(2):59-63.
116. Lutz MW, Warren PV, Gill RW, Searls DB: Managing genomic and proteomic knowledge. Drug Disc Today (2005) 2(3):197-204.
117. Toner B: CSHL meeting goes beyond genome informatics to address networks, epigenomics, imaging. Bioinform (2005) November 07.
118. Spellman PT, Miller M, Stewart J, Troup C, Sarkans U, Chervitz S, Bernhart D, Sherlock G, Ball C, Lepage M, Swiatek M et al: Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol (2002) 3(9):RESEARCH0046.
119. Pedrioli PG, Eng JK, Hubley R, Vogelzang M, Deutsch EW, Raught B, Pratt B, Nilsson E, Angeletti RH, Apweiler R, Cheung K et al: A common open representation of mass spectrometry data and its application to proteomics research. Nat Biotechnol (2004) 22(11):1459-1466.
120. Quackenbush J: Data standards for 'omic' science. Nat Biotechnol (2004) 22(5):613-614.
121. Wang X, Gorlitsky R, Almeida JS: From XML to RDF: How semantic web technologies will change the design of the 'omic' standards. Nat Biotechnol (2005) 23(9):1099-1103. Provides a straightforward description of the benefits of RDF over XML.
122. W3C workshop on Semantic Web for life sciences: W3C World Wide Web consortium, Massachusetts Institute of Technology, Cambridge, MA, USA. http://www.w3.org/2004/07/swls-ws.html
123. Goble C, Stevens R, Bechhofer S: The Semantic Web and knowledge grids. Drug Disc Today (2005) 2(3):225-233.
124. Goebel G, Leitner, KL, Pfeiffer, K: Use of Semantic Web technologies in medicine and health care. Medinfo 2004, San Francisco, CA, USA (2004).
125. Gardner SP: Ontologies and semantic data integration. Drug Disc Today (2005) 10(14):1001-1007.
126. Stephens SM: Enabling Semantic Web inferencing with Oracle technology: Applications in life sciences. In: Lecture Notes in Computer Science. Adi A, Stoutenburg S, Tabet S (Eds), Springer-Verlag, Berlin, Germany (2005) 3791:8-16. Describes the first mainstream commercial implementation of an RDF store.
127. Cheung KH, Yip KY, Smith A, deKnikker R, Masiar A, Gerstein M: YeastHub: A Semantic Web use case for integrating data in the life sciences domain. Bioinformatics (2005) 21(Suppl 1):185-196. A comprehensive paper describing the integration of many biological datasets in RDF.
128. Semantic Web: W3C World Wide Web consortium, Massachusetts Institute of Technology, Cambridge, MA, USA. http://www.w3.org/2001/sw/
129. Neumann EK, Miller E, Wilbanks J: What the semantic web could do for the life sciences. Drug Disc Today Biosilico (2004) 2(6):228-236.
130. Manoia F, Miller E: W3C recommendation: RDF primer W3C World Wide Web consortium, Massachusetts Institute of Technology, Cambridge, MA, USA. http://www.w3.org/TR/rdf-primer/
131. Clark T, Martin S, Liefeld T: Globally distributed object identification for biological knowledgebases. Brief Bioinform (2004) 5(1):59-70.
132. Coles SJ, Day NE, Murray-Rust P, Rzepa HS, Zhang Y: Enhancements of the chemical Semantic Web through the use of InChl identifiers. Org Biomol Chem (2005) 3(10):1832-1834.
133. McGuinness DL, van Harmelen F: W3C recommendation: OWL Web Ontology Language overview: W3C World Wide Web consortium, ERCIM, Sophia-Antipolis, France. http://www.w3.org/TR/owl-features/
134. Goldbeck J, Fragoso G, Hartel F, Hendler J, Parsia B, Oberthaler J: The National Cancer Institute's thesaurus and ontology. J Web Semantics (2003) 1(1):1-5.
135. Kashyap V: The UMLS semantic network and the Semantic Web. (2003):351-355.
136. Luciano JS: PAX of mind for pathway researchers. Drug Disc Today (2005) 10(13):937-942.
137. Soldatova LN, King RD: Are the current ontologies in biology good ontologies? Nat Biotechnol (2005) 23(9):1095-1098. Provides an interesting discussion of how life sciences ontologies can be improved.
138. Gardner SP: Ontologies in drug discovery. Drug Disc Today Technol (2005) 2(3):235-240.